Efficacy and safety of rituximab in autoimmune and microangiopathic hemolytic anemia: A systematic review and meta-analysis

Chao S.-H.Chang Y.-L.Yen J.-C.Liao H.-T.Wu T.-H.CHIA-LI YUTsai C.-Y.Chou Y.-C.2021-01-272021-01-2720202162-3619https://www.scopus.com/inward/record.uri?eid=2-s2.0-85083426152&doi=10.1186%2fs40164-020-00163-5&partnerID=40&md5=deb247d231bf253790c1c0c8f5aa0b8bhttps://scholars.lib.ntu.edu.tw/handle/123456789/542151[SDGs]SDG3Efficacy and safety of rituximab in autoimmune and microangiopathic hemolytic anemia: A systematic review and meta-analysisreview10.1186/s40164-020-00163-52-s2.0-85083426152